Below are Gilead’s Research Scholar Program Solid Tumor Awardees and their research titles. As the program values diverse voices and innovative research topics to address areas of unmet medical need, you do not need to duplicate previous research topics in order to be successful for an Award.
Any basic, translational or clinical research research proposal that addresses an area of unmet medical need in Solid Tumors is welcome.
2023 Award Recipients
Sihan Wu, PhD
UT Southwestern Medical Center
"Understanding the Molecular Mechanisms of Extrachromosomal DNA Segregation in Cancer"
Maria Soledad Sosa, PhD
Albert Einstein College of Medicine
"Novel therapeutic strategies to prevent melanoma metastasis"
Tejas Patil, MD
University of Colorado School of Medicine
"Use of spatial multiomics to characterize receptor tyrosine kinase adaptations of drug-tolerant persister cells in non-small cell lung cancer treated with tyrosine kinase inhibitors"
Shearwood McClelland III, MD
University Hospitals Seidman Cancer Center
"Navigator-Assisted Hypofractionation (NAVAH) to Address Radiation Therapy Access Disparities Facing African-Americans with Prostate Cancer"
2022 Award Recipients
Katherine Chiappinelli, PhD
The George Washington University
"Targeting RNA editing of transposable elements to reverse ovarian cancer immune evasion"
John McAuliffe, MD, PhD
Montefiore Medical Center, Albert Einstein College of Medicine
"Identifying and Inhibiting Intravasation in Pancreatic Adenocarcinoma (PDAC)"
Joshua Veatch, MD, PhD
Fred Hutchinson Cancer Center
"Development of increased potency tumor specific CD4 T cell products for cancer treatment"
Neil Vasan, MD, PhD
Columbia University Medical Center
"Large-scale functional analysis of PIK3CA variants in cancer"